Font Size:
a
A
A
Keyword [TKI-resistance]
Result: 21 - 40 | Page: 2 of 3
21.
The Clinical Application And The Optimization Strategy Of Metformin In Overcoming EGFR-TKI Resistance
22.
Study On The Inhibitory Effects Of FGFR Inhibitor PRN1371 Combined With Gefitinib On EGFR-TKI Resistance In Non-small Cell Lung Cancer And Its Mechanism
23.
Clinical Study Of T790M Mutation In Blood Of Non-small Cell Lung Cancer Patients With EGFR-TKI Resistance Using NGS Technology
24.
Modulation Of ALDHA1 Activity Reverses Stem-like Cell-mediated EGFR-TKI Resistance In NSCLC
25.
Effect Of TP53 And EGFR Gene Co-mutation On The Efficacy Of EGFR-TKIs In Patients With Advanced Lung Adenocarcinoma
26.
The Association Study Of Non-small Cell Lung Cancer Radiosensitivity Between Epidermal Growth Factor Receptor Gene Status And EGFR-TKI Resistance
27.
The Early Resistance Mechanism Study Of Egfr Sensitive Mutant Non Small Cell Lung Cancer Patients After EGFR-TKI Treatment
28.
The Role And Mechanism Of TGF-?/IL-11/STAT3 Axis In EGFR TKI Resistant Lung Adenocarcinomas
29.
Research On Mechanism Of Resistance To Tyrosine Kinase Inhibitors In Chronic Myeloid Leukemia Based On Deep Sequeincng And Multi-omics Approach
30.
SIRT6 Regulates Glycolysis To Mediate Erotinib Resistance In Non-small Cell Lung Cancer
31.
Bevacizumab Plus EGFR-TKI Combination After Acquired Resistance To Tkis In T790M(-)EGFR-sensitive Mutations NSCLC Patients: A Single Arm Observational Study
32.
The Role And Underlying Mechanism Of CA916798 In Acquired EGFR-TKI-Resistance In NSCLC
33.
Exploration Of NK Cells Function And Megakaryocytes-related Proteins In CML Patients With TKI-resistance
34.
A role for lipid rafts in EGFR TKI resistance in breast cancer
35.
EGFR-TKIs Resistances Increase PD-L1 Expression And Promote De Novo Synthesis Of Fatty Acid In EGFR Mutant Non-Small Cell Lung Cancer
36.
Effect And Mechanism Of LncRNA H19 Downregulation Confers EGFR-TKI Resistance In EGFR-mutant Lung Cancers
37.
Targeting DNA-PK Overcomes Acquired Resistance To Third-Generation EGFR-TKi Osimertinib In Non-Small Cell Lung Cancer
38.
Research On The Function And Mechanism Of SOX3 Gene Mutation In EGFR-TKI Resistance Of Lung Adenocarcinama
39.
Quantitative Proteomics Research Of Nucleic Acid Binding Proteins And Serum And Their Application In Lung Cancer
40.
Multi-scale Analysis Of The Mechanism Of Fuzhengkangai Combined Gefitinib For Inhibition Proliferation Of Drug Resistance Of Non-small Cell Lung Cancer
<<First
<Prev
Next>
Last>>
Jump to